First-line treatment of chronic lymphocytic leukemia with ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab: final analysis of the randomized, phase 3 iLLUMINATE trial.

Creative Commons License

Moreno C., Greil R., Demirkan F., Tedeschi A., Anz B., Larratt L., ...More

Haematologica, 2022 (SCI-Expanded) identifier

  • Publication Type: Article / Article
  • Volume:
  • Publication Date: 2022
  • Doi Number: 10.3324/haematol.2021.279012
  • Journal Name: Haematologica
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, EMBASE, MEDLINE, Directory of Open Access Journals
  • Dokuz Eylül University Affiliated: Yes